Guidehealth

A hybrid model where the AI is real but the delivery is human. The company describes a proprietary AI built for real world care alongside Healthguides, virtually embedded medical assistants trained in data science working under licensed clinical supervision, and generative AI risk predictive models used by those Healthguides to engage patients and coordinate care. The AI predicts which patients need support; people then do the outreach and coordination. A buyer is purchasing a staffed service augmented by models, not software, and should size the engagement accordingly.

Oversight is structural and unusually clear because a licensed human sits between the model and the patient by design. Healthguides operate under licensed clinical professionals and extend the reach of the care team rather than substituting for it, and the predictive output informs prioritization rather than making clinical decisions. The tradeoff is that the model's influence is indirect and therefore harder to audit: a risk score that quietly shapes who gets outreach is consequential even though no clinical decision is formally delegated to it.

The company names a proprietary AI and describes a combination of its own models with commercially available AI point solutions under one contract, plus a stated intent to move from predictive toward prescriptive analytics. That is more architectural candor than most services businesses offer, and acknowledging reliance on third party models rather than claiming everything is proprietary is to its credit. No model documentation, validation methodology, or performance figures are published.

The evidence is institutional rather than statistical, and it is substantial. A large academic health system reported significantly improved CMS star ratings following its collaboration with the company, then invested 10 million dollars in it, which is a costly form of endorsement. Another major health system participated in its seed round. The platform is reported to support more than 500,000 lives. What is missing is published outcome or total cost of care data with methodology, so buyers have strong signals of customer satisfaction and weak evidence of measured effect.

No published PHI framework or AI safety disclosure was located. The company operates as an extension of provider organizations with staff working inside partner workflows on identifiable patient data, so the PHI surface is broad and continuous rather than transactional.

No HIPAA or BAA statement was located in public materials. Business associate arrangements are structurally necessary given the embedded services model and are certain to exist contractually, but nothing is published.

No SOC 2, HITRUST, or ISO 27001 attestation was located in public materials.

No FDA pathway applies. Risk stratification and care coordination for value based contracts sit outside Software as a Medical Device. The regulatory regime that actually governs this vendor is the CMS accountable care and shared savings program rules its customers operate under, which is a payment regime rather than a device pathway.

No governance framework or bias evaluation was located, and this is the axis where the gap matters most for this vendor. A model that predicts which patients most need support is allocating a scarce human resource, and if the underlying data reflects historical access disparities, the model can reproduce them while appearing to optimize. Nothing published indicates whether that is measured.

The company states its platform and staff integrate directly into primary care workflows and that it handles referrals, scheduling, prior authorization, and utilization management, which implies working inside customer systems. The data analytics foundation came from an acquired value based care services division with a licensing agreement for that vendor's analytics platform. No named EHR integrations, HL7, or FHIR capability were located, so depth is asserted operationally rather than documented technically.

Described as a cloud based solution. No tenancy, hosting, or data residency detail was located beyond that characterization.

No published pricing. The company describes an affordable operating model and offers technology plus staffing plus AI point solutions under a single contract, which is a real simplification for a buyer managing multiple vendors, but the economics are undisclosed. The central commercial question, whether compensation is fee based or tied to shared savings performance, is not addressed publicly and materially changes the risk a health system takes on.

Scoped to value based primary care for health systems, provider networks, and clinically integrated networks, spanning accountable care arrangements across lines of business. Coverage extends through partnerships rather than internal build, including a virtual cardiology program for at risk heart failure, hypertension, and arrhythmia patients, and an advance care planning partner. Specialty depth is therefore partner dependent, and the core competency is primary care panel management.